Cargando…

Identification of IL20RB as a Novel Prognostic and Therapeutic Biomarker in Clear Cell Renal Cell Carcinoma

BACKGROUND: Clear cell renal cell carcinoma (ccRCC) is a type of life-threatening malignant tumor of the urinary system. IL20RB, interleukin 20 receptor subunit beta, is a cytokine receptor subunit coding gene and was initially found to play a vital role in human cancers, while its role in ccRCC sti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Guo, Hongda, Jiang, Songlin, Sun, Haoyu, Shi, Benkang, Li, Yan, Zhou, Nan, Zhang, Dongqing, Guo, Hu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8923803/ https://www.ncbi.nlm.nih.gov/pubmed/35299868 http://dx.doi.org/10.1155/2022/9443407

Ejemplares similares

Prognostic Role of the Ubiquitin Proteasome System in Clear Cell Renal Cell Carcinoma: A Bioinformatic Perspective
por: Guo, Hongda, et al.
Publicado: (2021)

Interleukin 20 receptor subunit beta (IL20RB) predicts poor prognosis and regulates immune cell infiltration in clear cell renal cell carcinoma
por: Zhang, Haoxun, et al.
Publicado: (2022)

GSDMs are potential therapeutic targets and prognostic biomarkers in clear cell renal cell carcinoma
por: Yao, Lei, et al.
Publicado: (2022)

Diagnostic and Prognostic Biomarkers in Renal Clear Cell Carcinoma
por: Weaver, Chaston, et al.
Publicado: (2022)

Adipophilin as prognostic biomarker in clear cell renal cell carcinoma
por: Tolkach, Yuri, et al.
Publicado: (2017)

TYROBP is a potential prognostic biomarker of clear cell renal cell carcinoma
por: Wu, Ping, et al.
Publicado: (2020)

Renal capsular invasion is a prognostic biomarker in localized clear cell renal cell carcinoma
por: Ha, U-Syn, et al.
Publicado: (2018)

Aberrant Methylation of PCDH8 is a Potential Prognostic Biomarker for Patients with Clear Cell Renal Cell Carcinoma
por: Lin, Ying-Li, et al.
Publicado: (2014)

IL2RB Is a Prognostic Biomarker Associated with Immune Infiltrates in Pan-Cancer
por: Li, Guangyao, et al.
Publicado: (2022)

Prognostic implications of Aquaporin 9 expression in clear cell renal cell carcinoma
por: Xu, Wen-Hao, et al.
Publicado: (2019)

Overexpression of interleukin-20 receptor subunit beta (IL20RB) correlates with cell proliferation, invasion and migration enhancement and poor prognosis in papillary renal cell carcinoma
por: Cui, Xi-Feng, et al.
Publicado: (2019)

TREM-1 as a potential prognostic biomarker associated with immune infiltration in clear cell renal cell carcinoma
por: Pu, Yaling, et al.
Publicado: (2023)

EVI1 as a Prognostic and Predictive Biomarker of Clear Cell Renal Cell Carcinoma
por: Palomero, Luis, et al.
Publicado: (2020)

The SLC Family Are Candidate Diagnostic and Prognostic Biomarkers in Clear Cell Renal Cell Carcinoma
por: Kang, Weiting, et al.
Publicado: (2020)

LRRK2 is a candidate prognostic biomarker for clear cell renal cell carcinoma
por: Yang, Chunxiu, et al.
Publicado: (2021)

Identification of CXCL10 as a Prognostic Biomarker for Clear Cell Renal Cell Carcinoma
por: Qu, Genyi, et al.
Publicado: (2022)

LAMTOR3 is a prognostic biomarker in kidney renal clear cell carcinoma
por: Gong, Yun, et al.
Publicado: (2022)

The IL-20RB receptor and the IL-20 signaling pathway in regulating host defense in oral mucosal candidiasis
por: Beute, John E., et al.
Publicado: (2022)

Identification of KIF20A as a tumor biomarker and forwarder of clear cell renal cell carcinoma
por: Xiao, Wen, et al.
Publicado: (2021)

Combined Vhl, Trp53 and Rb1 mutation causes clear cell renal cell carcinoma in mice
por: Harlander, Sabine, et al.
Publicado: (2017)

Retracted: IL2RB Is a Prognostic Biomarker Associated with Immune Infiltrates in Pan-Cancer
por: Oncology, Journal of
Publicado: (2023)

Identification of an individualized autophagy prognostic index in clear cell renal cell carcinoma patients
por: Jin, Yi, et al.
Publicado: (2020)

NCF1/2/4 Are Prognostic Biomarkers Related to the Immune Infiltration of Kidney Renal Clear Cell Carcinoma
por: Chen, Yifei, et al.
Publicado: (2021)

Publisher Correction: Renal capsular invasion is a prognostic biomarker in localized clear cell renal cell carcinoma
por: Ha, U-Syn, et al.
Publicado: (2018)

Systematic Evaluation of the Prognostic Impact and Intratumour Heterogeneity of Clear Cell Renal Cell Carcinoma Biomarkers
por: Gulati, Sakshi, et al.
Publicado: (2014)

Copy number variations and expression of MPDZ are prognostic biomarkers for clear cell renal cell carcinoma
por: Huang, Yong-Sheng, et al.
Publicado: (2017)

The CSRNP Gene Family Serves as a Prognostic Biomarker in Clear Cell Renal Cell Carcinoma
por: Zhang, Huaru, et al.
Publicado: (2021)

Corrigendum to “The SLC Family Are Candidate Diagnostic and Prognostic Biomarkers in Clear Cell Renal Cell Carcinoma”
por: Kang, Weiting, et al.
Publicado: (2020)

Loss of DUSP4 Expression as a Prognostic Biomarker in Clear Cell Renal Cell Carcinoma
por: Bang, Seongsik, et al.
Publicado: (2021)

Glycolysis-Related Genes Serve as Potential Prognostic Biomarkers in Clear Cell Renal Cell Carcinoma
por: Zhang, Yan, et al.
Publicado: (2021)

ALDOB represents a potential prognostic biomarker for patients with clear cell renal cell carcinoma
por: Shao, Yuan, et al.
Publicado: (2023)

Homologous recombination deficiency serves as a prognostic biomarker in clear cell renal cell carcinoma
por: He, Liping, et al.
Publicado: (2023)

ISG20 serves as a potential biomarker and drives tumor progression in clear cell renal cell carcinoma
por: Xu, Tianbo, et al.
Publicado: (2020)

NCKAP1 is a Prognostic Biomarker for Inhibition of Cell Growth in Clear Cell Renal Cell Carcinoma
por: Chen, Jiasheng, et al.
Publicado: (2022)

Four methylation‐driven genes may be prognostic biomarkers in clear cell renal carcinoma
por: Yin, Hang, et al.
Publicado: (2020)

The Prognostic Assessment of CDC20 in Patients with Renal Clear Cell Carcinoma and Its Relationship with Body Immunity
por: Shi, Jiaqi, et al.
Publicado: (2022)

Comprehensive analysis of FRAS1/FREM family as potential biomarkers and therapeutic targets in renal clear cell carcinoma
por: Wang, Ganggang, et al.
Publicado: (2022)

Identification of ACSL4 as a biomarker and contributor of ferroptosis in clear cell renal cell carcinoma
por: Guo, Na
Publicado: (2022)

Prognostic Signatures and Therapeutic Value Based on the Notch Pathway in Renal Clear Cell Carcinoma
por: Li, Ziyao, et al.
Publicado: (2022)

Genomic Analysis Reveals Novel Specific Metastatic Mutations in Chinese Clear Cell Renal Cell Carcinoma
por: Meng, Hui, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_3nnndb0ftv07biqvadjktbc69m